Merck (MRK) Pilots Blockchain Cocoa Tracking With A New Digital Passport Push

• Merck (NYSE:MRK) is partnering with The Hashgraph Group and PwC Germany on a <a href="https://xpertsstudio.com/american-express-harnessed-blockchain-to-create-amex-passport/” title=”American Express harnessed blockchain to create Amex Passport”>blockchain-based cocoa traceability and digital product passport pilot.
• The project applies Merck’s M-Trust physical authentication technology to cocoa supply chains in the food and agriculture sector.
• The pilot is designed to support transparency, sustainability reporting, and regulatory compliance requirements such as deforestation due diligence and digital product passports.

For investors tracking how supply chain traceability and reh a closer look through 9 top copper producer stocks

Merck is a global healthcare group with a market value of about $370.9b. This cocoa traceability pilot shows how a large pharmaceuticals player is testing its laboratory grade authentication tools in a heavily scrutinised food supply chain.

Beyond the headline: 5 risks and 2 things going right for Merck that every investor should see.

How does this cocoa pilot fit Merck’s broader strategy?

The cocoa traceability project gives Merck a way to apply its M-Trust authentication tools outside core biopharma, into food and agriculture supply chains. That lines up with the Narrative focus on turning a much larger pipeline and technology base into multiple growth drivers across different regulated industries, not just oncology.

Does this change the Merck Narrative investors have been using?

This pilot leans into a key Narrative catalyst, Merck’s push to turn R&D and acquired capabilities into more than 20 growth drivers with significant commercial potential. Extending M-Trust and digital product passports into sectors like food, luxury goods and electronics shows how the firm is testing new use cases that could help offset longer term risks such as KEYTRUDA’s loss of exclusivity.

If we take a look at the community Narrative for Merck, we can see how this news fits into the bigger investment story.

For Merck, what should investors watch next from this project?

The next useful marker is whether the cocoa pilot converts into paid rollouts or expanded trials with additional brands and categories over the next 12 to 18 months, especially in Europe where EUDR and ESPR rules apply first. Concrete adoption metrics such as number of product SKUs or suppliers brought onto TrackTrace with M-Trust integration will show how commercially scalable the concept is.

For the full picture including more risks and rewards, check out the complete Merck analysis.

This article by Simply Wall St is general in nature. We provide commentary based on historical data
and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your
financial situation. We aim to bring you long-term focused analysis driven by fundamental data.
Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.
Simply Wall St has no position in any stocks mentioned.

New:Manage All Your Stock Portfolios in One Place

We’ve created the ultimate portfolio companion for stock investors, and it’s free.

• Connect an unlimited number of Portfolios and see your total in one currency
• Be alerted to new Warning Signs or Risks

Have feedback on this article? Concerned about the content? Get in touch with us directly.Alternatively, email editorial-team@simplywallst.com

The most boring corner of the market just hit a 50-year low against stocks. History says that’s when it’s worth paying attention.

Supply-driven inflation breaks stocks and bonds at the same time. That is the one scenario commodities cover and nothing else does.

What the graphs says is that S&P 500 is just too expensive

Mitchell Lawler
Market Insights

What 13F filings won’t tell you about a billionaire’s stock picks

Fresh 13F filings are where some investors go to find their next stock pick. The problem is it’s missing some of the most important details for making a good investment.
73
Sep 4, 2026

About NYSE:MRK

Merck

Operates as a healthcare company worldwide.

Moderate risk with reasonable growth potential and pays a dividend.

Similar Companies

• Eli Lilly

• Johnson & Johnson

Market Insights

What 13F filings won’t tell you about a billionaire’s stock picksMI
Mitchell Lawler
Great earnings season, but are the earnings real?AN
Andrew Legget
Which payment stocks actually get paid?MI
Mitchell Lawler
Advertisement

Weekly Picks

Lou_Baseneseon Oncolytics Biotech·21 days ago

The Team Behind a $2 Billion Johnson & Johnson (JNJ) Deal Just Took Over This $105 Million Cancer Biotech

Fair Value:US$3.575.9% undervalued
71followersusers have followed this narrative
·1commentusers have commented on this narrative
·18likesusers have liked this narrative
WE

WealthAPon Copart·about 2 months ago

Copart’s Share Price Fell. Its Moat Did Not.

Fair Value:US$4931.2% undervalued
13followersusers have followed this narrative
·1commentusers have commented on this narrative
·2likesusers have liked this narrative
IV

Ivoedon ASML Holding·about 1 month ago

ASML’s China Sell-Off Looks Overdone, Yet The Shares Are Not Cheap

Fair Value:€1.78k15.7% undervalued
14followersusers have followed this narrative
·0commentsusers have commented on this narrative
·1likeusers have liked this narrative
FU

FundamentalContrarianInvestoron Universal Music Group·15 days ago

Universal Music Group: The Market Is Pricing the Quarter, Not the Catalogue

Fair Value:€23.2539.2% undervalued
6followersusers have followed this narrative
·0commentsusers have commented on this narrative
·1likeusers have liked this narrative

RecentlyUpdated Narratives

FRAGMENTSon Xerox Holdings·36 minutes ago

Xerox Is Worth About $436 Million. It Has $4.36 Billion of Debt. What Can Still Reach One Share?

Fair Value:US$3.515.4% undervalued
1followerusers have followed this narrative
·0commentsusers have commented on this narrative
·0likesusers have liked this narrative
FR

FRAGMENTSon Cato·about 1 hour ago

Cato Is Worth $53 Million. It Has $93.8 Million in Cash and Investments. The Retailer Is the Problem.

Fair Value:US$5.350.9% undervalued
1followerusers have followed this narrative
·0commentsusers have commented on this narrative
·0likesusers have liked this narrative
DA

davidlsanderon Ubisoft Entertainment·about 7 hours ago

Is Ubisoft the Market’s Biggest Pricing Error? Why Forensic Value Points to €33 Per Share

Fair Value:€33.885.6% undervalued
96followersusers have followed this narrative
·8commentsusers have commented on this narrative
·0likesusers have liked this narrative

Popular Narratives

AnalystConsensusTargeton NVIDIA·about 1 month ago

NVDA: Expanding AI Demand Will Drive Major Data Center Investments Through 2026

Fair Value:US$302.8323.9% undervalued
1385followersusers have followed this narrative
·8commentsusers have commented on this narrative
·35likesusers have liked this narrative
JO

John_Ericon MercadoLibre·4 days ago

MercadoLibre and the Spreadsheet Trick That Decides Everything

Fair Value:US$3.68k46.2% undervalued
131followersusers have followed this narrative
·3commentsusers have commented on this narrative
·18likesusers have liked this narrative
AN

AnalystConsensusTargeton Amazon.com·25 days ago

AMZN: Acceleration In Cloud And AI Will Drive Margin Expansion Ahead

Fair Value:US$32720.9% undervalued
1607followersusers have followed this narrative
·1commentusers have commented on this narrative
·15likesusers have liked this narrative

Source: simplywall.st